APO RESEARCH · REPORT
Microneedle Drug Delivery Systems
Microneedle drug delivery systems usually include Hollow Microneedle Technology microneedle and Dissolving Microneedles Technology microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.
Product & engineering
Understand the product.
Microneedle drug delivery systems usually include Hollow Microneedle Technology microneedle and Dissolving Microneedles Technology microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.
In this report, we mainly study the forecast market due to there is no product on the market, most product on the research.
Selected research
Industry Research
Microneedle Drug Delivery Systems Industry Research Report 2026
Market perspective
Microneedle drug delivery systems usually include Hollow Microneedle Technology microneedle and Dissolving Microneedles Technology microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.
In this report, we mainly study the forecast market due to there is no product on the market, most product on the research.
Microneedles are a rapidly growing technology developed to solve issues surrounding intradermal drug administration. While many microneedle platforms have been developed over nearly 2 decades, the issues and concerns remain largely the same.
Read the full market overview
The classification of Microneedle Drug Delivery Systems includes Hollow Microneedle Technology, Solid Microneedle Technology and Dissolving Microneedles Technology, and the proportion of Hollow Microneedle Technology occupies the most proportions.
Microneedle Drug Delivery Systems is widely used in Drug Delivery, Vaccine Delivery and other field. The most proportion of Microneedle Drug Delivery Systems is used for vaccine delivery.
3M, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Scope
This report quantifies the global Microneedle Drug Delivery Systems market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Microneedle Drug Delivery Systems.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Microneedle Drug Delivery Systems Market by Company
KINDEVA
Zosano Pharma
Becton-Dickinson(BD)Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect, Inc
Vaxxas
Lohmann Therapie-Systeme AG
Microneedle Drug Delivery Systems Segment by Type
Hollow Microneedle Technology
Solid Microneedle Technology
Dissolving Microneedles Technology
Microneedle Drug Delivery Systems Segment by Application
Drug Delivery
Vaccine Delivery
Microneedle Drug Delivery Systems Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microneedle Drug Delivery Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microneedle Drug Delivery Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microneedle Drug Delivery Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Microneedle Drug Delivery Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hollow Microneedle Technology
- Solid Microneedle Technology
- Dissolving Microneedles Technology
Applications
- Drug Delivery
- Vaccine Delivery
Companies covered
- KINDEVA
- Zosano Pharma
- Becton-Dickinson(BD)Technologies
- Nanopass Technologies
- Corium
- Valeritas
- Nitto
- Microdermics
- TheraJect, Inc
- Vaxxas
- Lohmann Therapie-Systeme AG
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Microneedle Drug Delivery Systems by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Hollow Microneedle Technology
- 2.2.3 Solid Microneedle Technology
- 2.2.4 Dissolving Microneedles Technology
- 2.3 Microneedle Drug Delivery Systems by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug Delivery
- 2.3.3 Vaccine Delivery
- 2.4 Assumptions and Limitations
3 Microneedle Drug Delivery Systems Breakdown Data by Type
- 3.1 Global Microneedle Drug Delivery Systems Historic Market Size by Type (2021-2026)
- 3.2 Global Microneedle Drug Delivery Systems Forecasted Market Size by Type (2027-2032)
4 Microneedle Drug Delivery Systems Breakdown Data by Application
- 4.1 Global Microneedle Drug Delivery Systems Historic Market Size by Application (2021-2026)
- 4.2 Global Microneedle Drug Delivery Systems Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Microneedle Drug Delivery Systems Market Perspective (2021-2032)
- 5.2 Global Microneedle Drug Delivery Systems Growth Trends by Region
- 5.2.1 Global Microneedle Drug Delivery Systems Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Microneedle Drug Delivery Systems Historic Market Size by Region (2021-2026)
- 5.2.3 Microneedle Drug Delivery Systems Forecasted Market Size by Region (2027-2032)
- 5.3 Microneedle Drug Delivery Systems Market Dynamics
- 5.3.1 Microneedle Drug Delivery Systems Industry Trends
- 5.3.2 Microneedle Drug Delivery Systems Market Drivers
- 5.3.3 Microneedle Drug Delivery Systems Market Challenges
- 5.3.4 Microneedle Drug Delivery Systems Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Microneedle Drug Delivery Systems Players by Revenue
- 6.1.1 Global Top Microneedle Drug Delivery Systems Players by Revenue (2021-2026)
- 6.1.2 Global Microneedle Drug Delivery Systems Revenue Market Share by Players (2021-2026)
- 6.2 Global Microneedle Drug Delivery Systems Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Microneedle Drug Delivery Systems Head Office and Area Served
- 6.4 Global Microneedle Drug Delivery Systems Players, Product Type & Application
- 6.5 Global Microneedle Drug Delivery Systems Manufacturers Established Date
- 6.6 Global Microneedle Drug Delivery Systems Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Microneedle Drug Delivery Systems Market Size (2021-2032)
- 7.2 North America Microneedle Drug Delivery Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Microneedle Drug Delivery Systems Market Size by Country (2021-2026)
- 7.4 North America Microneedle Drug Delivery Systems Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Microneedle Drug Delivery Systems Market Size (2021-2032)
- 8.2 Europe Microneedle Drug Delivery Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Microneedle Drug Delivery Systems Market Size by Country (2021-2026)
- 8.4 Europe Microneedle Drug Delivery Systems Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Microneedle Drug Delivery Systems Market Size (2021-2032)
- 9.2 Asia-Pacific Microneedle Drug Delivery Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Microneedle Drug Delivery Systems Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Microneedle Drug Delivery Systems Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Microneedle Drug Delivery Systems Market Size (2021-2032)
- 10.2 South America Microneedle Drug Delivery Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Microneedle Drug Delivery Systems Market Size by Country (2021-2026)
- 10.4 South America Microneedle Drug Delivery Systems Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Microneedle Drug Delivery Systems Market Size (2021-2032)
- 11.2 Middle East & Africa Microneedle Drug Delivery Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Microneedle Drug Delivery Systems Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Microneedle Drug Delivery Systems Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 KINDEVA
- 12.1.1 KINDEVA Company Information
- 12.1.2 KINDEVA Business Overview
- 12.1.3 KINDEVA Revenue in Microneedle Drug Delivery Systems Business (2021-2026)
- 12.1.4 KINDEVA Microneedle Drug Delivery Systems Product Portfolio
- 12.1.5 KINDEVA Recent Developments
- 12.2 Zosano Pharma
- 12.2.1 Zosano Pharma Company Information
- 12.2.2 Zosano Pharma Business Overview
- 12.2.3 Zosano Pharma Revenue in Microneedle Drug Delivery Systems Business (2021-2026)
- 12.2.4 Zosano Pharma Microneedle Drug Delivery Systems Product Portfolio
- 12.2.5 Zosano Pharma Recent Developments
- 12.3 Becton-Dickinson(BD)Technologies
- 12.3.1 Becton-Dickinson(BD)Technologies Company Information
- 12.3.2 Becton-Dickinson(BD)Technologies Business Overview
- 12.3.3 Becton-Dickinson(BD)Technologies Revenue in Microneedle Drug Delivery Systems Business (2021-2026)
- 12.3.4 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Product Portfolio
- 12.3.5 Becton-Dickinson(BD)Technologies Recent Developments
- 12.4 Nanopass Technologies
- 12.4.1 Nanopass Technologies Company Information
- 12.4.2 Nanopass Technologies Business Overview
- 12.4.3 Nanopass Technologies Revenue in Microneedle Drug Delivery Systems Business (2021-2026)
- 12.4.4 Nanopass Technologies Microneedle Drug Delivery Systems Product Portfolio
- 12.4.5 Nanopass Technologies Recent Developments
- 12.5 Corium
- 12.5.1 Corium Company Information
- 12.5.2 Corium Business Overview
- 12.5.3 Corium Revenue in Microneedle Drug Delivery Systems Business (2021-2026)
- 12.5.4 Corium Microneedle Drug Delivery Systems Product Portfolio
- 12.5.5 Corium Recent Developments
- 12.6 Valeritas
- 12.6.1 Valeritas Company Information
- 12.6.2 Valeritas Business Overview
- 12.6.3 Valeritas Revenue in Microneedle Drug Delivery Systems Business (2021-2026)
- 12.6.4 Valeritas Microneedle Drug Delivery Systems Product Portfolio
- 12.6.5 Valeritas Recent Developments
- 12.7 Nitto
- 12.7.1 Nitto Company Information
- 12.7.2 Nitto Business Overview
- 12.7.3 Nitto Revenue in Microneedle Drug Delivery Systems Business (2021-2026)
- 12.7.4 Nitto Microneedle Drug Delivery Systems Product Portfolio
- 12.7.5 Nitto Recent Developments
- 12.8 Microdermics
- 12.8.1 Microdermics Company Information
- 12.8.2 Microdermics Business Overview
- 12.8.3 Microdermics Revenue in Microneedle Drug Delivery Systems Business (2021-2026)
- 12.8.4 Microdermics Microneedle Drug Delivery Systems Product Portfolio
- 12.8.5 Microdermics Recent Developments
- 12.9 TheraJect, Inc
- 12.9.1 TheraJect, Inc Company Information
- 12.9.2 TheraJect, Inc Business Overview
- 12.9.3 TheraJect, Inc Revenue in Microneedle Drug Delivery Systems Business (2021-2026)
- 12.9.4 TheraJect, Inc Microneedle Drug Delivery Systems Product Portfolio
- 12.9.5 TheraJect, Inc Recent Developments
- 12.10 Vaxxas
- 12.10.1 Vaxxas Company Information
- 12.10.2 Vaxxas Business Overview
- 12.10.3 Vaxxas Revenue in Microneedle Drug Delivery Systems Business (2021-2026)
- 12.10.4 Vaxxas Microneedle Drug Delivery Systems Product Portfolio
- 12.10.5 Vaxxas Recent Developments
- 12.11 Lohmann Therapie-Systeme AG
- 12.11.1 Lohmann Therapie-Systeme AG Company Information
- 12.11.2 Lohmann Therapie-Systeme AG Business Overview
- 12.11.3 Lohmann Therapie-Systeme AG Revenue in Microneedle Drug Delivery Systems Business (2021-2026)
- 12.11.4 Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Product Portfolio
- 12.11.5 Lohmann Therapie-Systeme AG Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst